FIGURE

Figure 7

ID

ZDB-FIG-230615-12

Publication

Schellens et al., 2023 - A protein domain-oriented approach to expand the opportunities of therapeutic exon skipping for USH2A-associated retinitis pigmentosa

Other Figures

All Figure Page

Back to All Figure Page

Figure 7

Validation of ASO-induced dual exon skipping for USH2A exons 30–31 and USH2A exons 39–40 in WERI-Rb-1 cells

Co-transfection of WERI-Rb-1 cells with ASOs targeting either (A) exons 30 and 31 or (B) exons 39 and 40, resulted in the combined skipping of the exons of interest. Co-transfection of WERI-Rb-1 cells with ASOs targeting exons 30 and 31 also resulted in additional skipping of exon 32. In WERI-Rb-1 cells treated with ASOs targeting exons 39 and 40, no detectable amounts of alternatively spliced transcripts different from untransfected samples were present. GAPDH amplification is shown as a loading control. ASO, antisense oligonucleotide; mmASO, mismatch ASO; PCR(−), negative PCR control.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Mol Ther Nucleic Acids